Evidence map›Paper›PMID 36896315›Full record

ArticleIranian journal of pharmaceutical research : IJPR2022

Potential Benefits of

Sry Suryani Widjaja, Imam Bagus Sumantri, Rusdiana Rusdiana, Hendri Yo, Juli Jamnasi, Rudi Yo, Hendrik Kho, Vito Filbert Jayalie, Montesque Silalahi, Fauzie Siregar

Open access · hybridAbstract read
In one paragraph

Article in Iranian journal of pharmaceutical research : IJPR, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.7field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Sry Suryani WidjajaBiochemistry Department, Faculty of Medicine, University of Sumatera Utara, Medan, Indonesia.ORCID https://orcid.org/0000-0001-9738-9339
Imam Bagus SumantriFaculty of Pharmacy, University of Sumatera Utara, Medan, Indonesia.
Rusdiana RusdianaBiochemistry Department, Faculty of Medicine, University of Sumatera Utara, Medan, Indonesia.ORCID https://orcid.org/0000-0002-7308-9291
Hendri YoOncology Radiation Department, Murni Teguh Memorial Hospital, Medan, Indonesia.
Juli JamnasiOncology Radiation Department, Murni Teguh Memorial Hospital, Medan, Indonesia.
Rudi YoOncology Radiation Department, Murni Teguh Memorial Hospital, Medan, Indonesia.
Hendrik KhoOncology Radiation Department, Murni Teguh Memorial Hospital, Medan, Indonesia.
Vito Filbert JayalieOncology Radiation Department, Faculty of Medicine, University of Indonesia, Depok City, Indonesia.ORCID https://orcid.org/0000-0002-4314-9740
Montesque SilalahiOncology Radiation Department, Murni Teguh Memorial Hospital, Medan, Indonesia.
Fauzie SiregarOncology Radiation Department, Murni Teguh Memorial Hospital, Medan, Indonesia.
Universitas Sumatera Utara · IDUniversity of Indonesia · ID

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: The main therapy for head and neck cancer is radiation, and one of the toxic effects of radiation is radiation dermatitis. Objectives: The present study aims to evaluate the potential benefits of Methods: A cohort study was conducted with eligible subjects, all head and neck cancer patients receiving radiation therapy selected in consecutive sampling. Samples were divided into two groups; either received Results: A total of 44 patients were grouped into intervention ( Conclusions: The combination of

Indexed as

Aloe veraHead and Neck CancerRadiation-Induced DermatitisRaphanus sativus var. longipinnatus

Identifiers

PMID36896315
PMCPMC9990509
OpenAlexW4317536053

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.